Lanfeng Biochemical announced that the company plans to issue shares to Xuhe Capital and Anhui Ximing. The total amount of capital raised will not exceed 300 million yuan. After deducting the issuance fees, all will be used to repay financial institution loans. The distribution target is a full subscription in cash, and the sales limit period is 36 months. This offering constitutes a related transaction and is subject to review by the shareholders' meeting, review by the Shenzhen Stock Exchange, and registration by the China Securities Regulatory Commission.

Lanfeng Biochemical announced that the company plans to issue shares to Xuhe Capital and Anhui Ximing. The total amount of capital raised will not exceed 300 million yuan. After deducting the issuance fees, all will be used to repay financial institution loans. The distribution target is a full subscription in cash, and the sales limit period is 36 months. This offering constitutes a related transaction and is subject to review by the shareholders' meeting, review by the Shenzhen Stock Exchange, and registration by the China Securities Regulatory Commission.